Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap244.82M
Enterprise Value35.13B
Trailing P/E0.03
Forward P/E0.02
CELG.RT
(NYSE)Bristol-Myers Squibb Company
$0.11-- (--)
Loading... - Market loading
Bristol-Myers Squibb Company (CELG.RT) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)0.01
Forward Price/Sales0.00
Price/Book (mrq)0.01
Price/FCF (ttm)0.02
Price/OCF (ttm)0.02
PEG Ratio0.00
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue0.72
EV/Earnings4.83
EV/EBITDA2.59
EV/EBIT3.53
EV/FCF2.95
Stock Price
Current price, 52-week range, and moving averages
Current Price$0.11
1-Day Change1.85%
52-Week High$0.27
52-Week Low$0.02
52-Week Change338.64%
YTD Change38.02%
1-Year Change175.00%
50-Day MA$0.11
200-Day MA$0.07
Avg Volume (30 day)61.95K
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding2.05B
Book Value per Share$9.82
Net Cash per Share$-17.04
FCF per Share$5.82
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin70.45%
EBITDA Margin (ttm)27.96%
EBIT Margin (ttm)20.55%
Operating Margin (ttm)20.55%
Pretax Margin (ttm)19.79%
Profit Margin (ttm)15.00%
FCF Margin (ttm)24.56%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)36.17%
Return on Assets (ttm)8.41%
Return on Invested Capital (ttm)13.72%
Return on Capital Employed (ttm)14.80%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue48.48B
Gross Profit34.16B
Operating Income9.96B
Pretax Income9.60B
Net Income7.27B
EBITDA13.55B
EBIT9.96B
Diluted EPS$3.56
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow13.31B
Capital Expenditures1.40B
Free Cash Flow11.91B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth1.78%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)86.48B
Cash & Securities (mrq)9.57B
Net Cash (mrq)-34.89B
Net Cash per Share$-17.04
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)44.46B
Working Capital (mrq)8.05B
Total Equity (mrq)20.10B
Book Value per Share$9.82
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.42
Quick Ratio (mrq)1.28
Debt/Equity (mrq)2.21
Debt/EBITDA (ttm)3.28
Debt/FCF (ttm)3.73
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield2969.51%
FCF Yield4863.96%
Buyback Yield-4.49%
Total Shareholder Yield-4.49%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score1.35
Piotroski F-Score8/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$28.05
Graham Upside/Downside25402.09%
Frequently Asked Questions About Bristol-Myers Squibb Company Statistics
What are the key financial metrics for CELG.RT?
Bristol-Myers Squibb Company (CELG.RT) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.
What is CELG.RT's valuation analysis?
The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Bristol-Myers Squibb Company is overvalued or undervalued.
How do I read CELG.RT's profitability ratios?
Bristol-Myers Squibb Company's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.
What do CELG.RT's debt ratios indicate?
The financial health section shows Bristol-Myers Squibb Company's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.
What is CELG.RT's dividend analysis?
The dividend section covers Bristol-Myers Squibb Company's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.